Overview
Yutaka Hanazono practices in Tokyo, Japan. Mr. Hanazono is rated as an Advanced expert by MediFind in the treatment of X-Linked Severe Combined Immunodeficiency. His top areas of expertise are X-Linked Severe Combined Immunodeficiency, Hemophilia B, Teratoma of the Mediastinum, and Severe Combined Immunodeficiency (SCID).
His clinical research consists of co-authoring 33 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 3 articles in the study of X-Linked Severe Combined Immunodeficiency.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Hemophilia BMr. Hanazono isAdvanced. Learn about Hemophilia B.
- X-Linked Severe Combined Immunodeficiency
- Experienced
- Blood ClotsMr. Hanazono isExperienced. Learn about Blood Clots.
- Hemophilia AMr. Hanazono isExperienced. Learn about Hemophilia A.
- Severe Combined Immunodeficiency (SCID)Mr. Hanazono isExperienced. Learn about Severe Combined Immunodeficiency (SCID).
- Teratoma of the MediastinumMr. Hanazono isExperienced. Learn about Teratoma of the Mediastinum.